These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hybrid alpha/beta-peptides: for-Met-Leu-Phe-OMe analogues containing geminally disubstituted beta2,2- and beta 3,3-amino acids at the central position. Mollica A; Paglialunga Paradisi M; Torino D; Spisani S; Lucente G Amino Acids; 2006 Jun; 30(4):453-9. PubMed ID: 16547648 [TBL] [Abstract][Full Text] [Related]
3. The importance of the peptide bond at position 2 in HCO-Met-Leu-Phe-OMe analogues as shown by studies on human neutrophils. Cavicchioni G; Breveglieri A; Boggian M; Vertuani G; Reali E; Spisani S J Pept Sci; 1996; 2(3):135-40. PubMed ID: 9231322 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe analogues incorporating spacer aminoacids at the lateral positions. Lucente G; Giordano C; Sansone A; Torino D; Spisani S Amino Acids; 2009 Jul; 37(2):285-95. PubMed ID: 18636221 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, conformation and biological activity of centrally modified pseudopeptidic analogues of For-Met-Leu-Phe-OMe. Giordano C; Lucente G; Masi A; Paglialunga Paradisi M; Sansone A; Spisani S Amino Acids; 2007 Sep; 33(3):477-87. PubMed ID: 17021652 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues. Mollica A; Feliciani F; Stefanucci A; Costante R; Lucente G; Pinnen F; Notaristefano D; Spisani S J Pept Sci; 2012 Jun; 18(6):418-26. PubMed ID: 22528501 [TBL] [Abstract][Full Text] [Related]
7. Synthetic formyl tripeptide chemoattractants: a C(alpha,alpha)-dialkylated, amphiphilic glycyl residue at position 1. Witkowska R; Zabrocki J; Spisani S; Falzarano MS; Toniolo C; Formaggio F J Pept Sci; 2003 Jun; 9(6):354-60. PubMed ID: 12846481 [TBL] [Abstract][Full Text] [Related]
8. Chemotactic tripeptides incorporating at position 2 alpha-aminoacid residues with unsaturated side chains. Lucente G; Paradisi MP; Giordano C; Sansone A; Torino D; Spisani S Amino Acids; 2008 Aug; 35(2):329-38. PubMed ID: 18163179 [TBL] [Abstract][Full Text] [Related]
9. Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity. Torino D; Mollica A; Pinnen F; Feliciani F; Spisani S; Lucente G Bioorg Med Chem; 2009 Jan; 17(1):251-9. PubMed ID: 19081258 [TBL] [Abstract][Full Text] [Related]
10. Hybrid alpha/beta3-peptides with proteinogenic side chains. Monosubstituted analogues of the chemotactic tripeptide For-Met-Leu-Phe-OMe. Giordano C; Lucente G; Mollica A; Nalli M; Pagani Zecchini G; Paglialunga Paradisi M; Gavuzzo E; Mazza F; Spisani S J Pept Sci; 2004 Aug; 10(8):510-23. PubMed ID: 15347138 [TBL] [Abstract][Full Text] [Related]
12. Conformationally restricted formyl methionyl tripeptide chemoattractants: a three-dimensional structure-activity study of analogs incorporating a C alpha,alpha-dialkylated glycine at position 2. Toniolo C; Crisma M; Valle G; Bonora GM; Polinelli S; Becker EL; Freer RJ; Sudhanand ; Rao RB; Balaram P Pept Res; 1989; 2(4):275-81. PubMed ID: 2520765 [TBL] [Abstract][Full Text] [Related]
13. Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH. Selvatici R; Falzarano S; Franceschetti L; Mollica A; Guerrini R; Siniscalchi A; Spisani S FEBS J; 2008 Feb; 275(3):449-57. PubMed ID: 18167144 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological activity and conformational studies of geometrically restricted tripeptide analogues of the chemoattractant HCO-Met-Leu-Phe-OMe. Boggian M; Vertuani G; Cavicchioni G; Pecoraro R; Scatturin A; Spisani S Farmaco; 1997; 52(6-7):439-44. PubMed ID: 9372595 [TBL] [Abstract][Full Text] [Related]
15. Chemotactic peptide analogues. Centrally constrained chemotactic N-formyltripeptides: synthesis, conformation, and activity of two new analogues. Pagani Zecchini G; Paglialunga Paradisi M; Torrini I; Lucente G; Mastropietro G; Paci M; Spisani S Arch Pharm (Weinheim); 1996 Dec; 329(12):517-23. PubMed ID: 9038418 [TBL] [Abstract][Full Text] [Related]
17. Modified chemotactic peptides: synthesis and biological activity of HCO-Met-delta ZLeu-delta ZPhe-OMe. Pagani Zecchini G; Torrini I; Paglialunga Paradisi M; Lucente G; Spisani S Farmaco; 1994 Nov; 40(11):739-42. PubMed ID: 7832975 [TBL] [Abstract][Full Text] [Related]
18. New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor. Spisani S; Fraulini A; Varani K; Falzarano S; Cavicchioni G Eur J Pharmacol; 2007 Jul; 567(1-2):171-6. PubMed ID: 17481605 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and properties of chemotactic peptide analogs. II. HCO-Met-Leu-Phe-OMe analogs containing cyclic alpha,alpha-disubstituted amino acids as Met and Phe mimicking residues. Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Spisani S; Giuliani AL Int J Pept Protein Res; 1991 Dec; 38(6):495-504. PubMed ID: 1668096 [TBL] [Abstract][Full Text] [Related]
20. For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides. Torrini I; Zecchini GP; Paradisi MP; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S Biopolymers; 1995 Apr; 35(4):347-58. PubMed ID: 7711275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]